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Is higher dairy consumption associated with lower body weight and
fewer metabolic disturbances? The Hoorn Study1–3
Marieke B Snijder, Amber AWA van der Heijden, Rob M van Dam, Coen DA Stehouwer, Gerrit J Hiddink, Giel Nijpels,
Robert J Heine, Lex M Bouter, and Jacqueline M Dekker
ABSTRACT
Background: Dairy consumption has been postulated to reduce the
risk of obesity and metabolic disturbances.
Objective: The aim of this study was to evaluate the associations of
dairy consumption with body weight and other components of the
metabolic syndrome.
Design: We used cross-sectional data for 2064 men and women aged
50–75 y who participated in the Hoorn Study. The metabolic syn-
drome was defined according to the National Cholesterol Education
Program Expert Panel. Dairy consumption was assessed by using a
semiquantitative food-frequency questionnaire.
Results: The median consumption of total dairy products was 4.1
servings/d. After adjustment for potential confounders (ie, dietary
factors, physical activity, smoking, income, educational level, and
antihypertensive medication), total dairy consumption was signifi-
cantly associated with lower diastolic blood pressure (  SE:
0.31  0.12 mm Hg/serving) and higher fasting glucose concen-
trations (0.04  0.02 mmol/L per serving), but not with body weight
or other metabolic variables (ie, lipids, postload glucose, or insulin).
When different dairy products were distinguished, borderline
significant (P  0.10) inverse associations were observed for dairy
desserts, milk, and yogurt with systolic (1.26  0.58, 0.57 
0.34, and 1.28  0.74 mm Hg/serving, respectively) and diastolic
(0.58  0.31, 0.57  0.18, and 0.35  0.40 mm Hg/serving,
respectively) blood pressure, whereas cheese consumption was pos-
itively associated with body mass index (0.15  0.08/serving).
Conclusion: In an elderly Dutch population, higher dairy consump-
tion was not associated with lower weight or more favorable levels
of components of the metabolic syndrome, except for a modest
association with lower blood pressure. Am J Clin Nutr 2007;85:
989–95.
KEY WORDS Dairy consumption, body weight, metabolic
syndrome, cross-sectional study, elderly
INTRODUCTION
The prevalence of overweight and obesity has increased enor-
mously, and it is strongly associated with cardiovascular disease
risk factors such as hyperglycemia, high blood pressure, and
dyslipidemia (1). The clustering of these risk factors is often
referred to as the metabolic syndrome and is associated with
elevated risk of cardiovascular morbidity and mortality (2).
Dairy consumption has been postulated to reduce the risk of
obesity and metabolic disturbances. Inverse relations between
dairy consumption and body weight (3–7) and between dairy
consumption and the risk of type 2 diabetes, the metabolic syn-
drome, and blood pressure (8–12) have been shown in observa-
tional studies. These associations are usually attributed to a
higher calcium intake, which has also been reported to be asso-
ciated with lower body weight and less weight gain (13, 14) and
lower blood pressure (15, 16). However, given the high correla-
tion between calcium and dairy consumption, the observed as-
sociations for calcium may also have reflected effects of other
dairy components.
Various components of dairy products have been suggested
as explanations for dairy products’ possible beneficial effects. First,
an increased intake of calcium could reduce 1,25-dihydroxyvitamin
D [1,25-(OH2)D] and thus intracellular calcium, which in turn may
stimulate lipolysis and inhibite lipogenesis in adipocytes (15) and
increase insulin sensitivity in adipocytes and muscle cells (17). In
addition,decreasedintracellularcalciumconcentrationsmayreduce
blood pressure by lowering vascular smooth muscle tone and pe-
ripheral vascular resistance (15). Other suggested mechanisms in-
clude insulinotropic effects of whey proteins (18) and beneficial
effects of magnesium on insulin sensitivity (19). Specific types of
dairyproductscouldhavedifferenteffectsonmetabolic traits (8,10)
because of such factors as differences in absorbability that result
from variations in the amount of lactose (20).
Although a beneficial effect of dairy consumption has repeat-
edly been reported, other important observational studies have
not supported these favorable effects of dairy consumption (21–
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23). In addition, small intervention studies with dairy supple-
mentation showed inconsistent results (24–28), and secondary
review of randomized dairy supplementation trials, although
they were not specifically designed to investigate the effect on
body weight, did not find that they showed any effect on body
weight (29). Such inconsistency of results may have been caused
by the heterogeneity of the various study populations and differ-
ences in the methods used.
Many of the previous studies on dairy consumption were per-
formed mainly in women (4, 21, 25, 26, 28), in men only (8, 23),
or in children or young adults (3, 5–7, 10, 11, 21, 22, 28). In the
present study, we investigated the association between dairy
consumption and components of the metabolic syndrome using
cross-sectional data from the population-based Hoorn Study co-
hort, which comprised elderly men and women who were exten-




The Hoorn Study is a population-based cohort study of glu-
cose tolerance in 2484 white men and women aged 50–75 y,
begun in 1989, that has been described in detail elsewhere (30).
Subjects who had missing data for dietary intake (n  78), body
mass index (BMI; (n  7), waist circumference (n  12), systolic
or diastolic blood pressure (n  2), HDL cholesterol (n  6),
LDL cholesterol (n  11), triacylglycerol (n  5), fasting glu-
cose (n  4), physical activity (n  295), smoking status (n 
21), income level (n  152), or educational level (n  147) were
excluded from all analyses. Therefore, the analyses were per-
formed in 1896 subjects (852 men and 1044 women).
Written informed consent was obtained from all participants.
Ethical approval for the study was obtained from the Ethical
Review Committee of the Vrije University Medical Center.
Measurements
Weight and height were measured while subjects were wear-
ing light clothing and no shoes. BMI was calculated as weight (in
kg) divided by height (in m2). Waist circumference was mea-
sured at the level midway between the lowest rib margin and the
iliac crest. Blood pressure (mm Hg) was measured in the right
arm by using a random-zero sphygmomanometer (Hawksley-
Gelma Ltd, Lancing, United Kingdom) while subjects were sit-
ting. Systolic and diastolic blood pressures were calculated as the
mean of duplicate measurements.
Fasting glucose concentration and 2-h postload glucose con-
centration after a 75-g oral-glucose-tolerance test (OGTT) were
measured in venous plasma (mmol/L) by using the glucose de-
hydrogenase method (Merck, Darmstadt, Germany). In subjects
already known to have diabetes, only a fasting blood sample was
taken. Fasting specific insulin concentration was quantified with
an insulin-specific double-antibody radioimmunoassay (anti-
body SP21; Linco, St Louis, MO). Serum lipids and lipoproteins
were measured by using enzymatic techniques (Boehringer-
Mannheim, Mannheim, Germany) as described previously (31).
All blood samples were analyzed at the hematologic clinical
chemistry laboratory of the Vrije University Medical Center.
The definition of the National Cholesterol Education Program
(NCEP) Expert Panel was used for the presence of the metabolic
syndrome and of the 5 individual components of the metabolic
syndrome (32). The metabolic syndrome was defined as the
presence of 3 of the following 5 components: elevated fasting
glucose (6.1 mmol/L), elevated triacylglycerol (1.7 mmol/
L), low HDL cholesterol (1.0 mmol/L in men or  1.3 mmol/L
in women), high blood pressure (130/85 mm Hg), and abdom-
inal obesity (waist  102 cm in men or  88 cm in women).
Information on lifestyle factors was obtained by a self-
administered questionnaire, checked by a personal interview.
Smoking status was categorized as current smoker or non-
smoker. Physical activity was expressed in the number of hours
of physical activity performed per day. The activities included
sports, bicycling, gardening, walking, doing odd jobs, and house-
keeping. Four categories of alcohol intake were used: non-
drinker, 10 g/d, 10–30 g/d, and 30 g/d. Level of income was
categorized as low, medium, or high. Tertiles of educational level
(low, Medium, and high) were created separately for men and
women.
Assessment of dairy consumption
A 92-item semiquantitative food-frequency questionnaire was
used to assess average food intakes, which included the con-
sumption of dairy products. Participants were asked about the
usual frequency of their consumption of dairy products and about
their average daily consumption. Answer-options were pre-
sented in average household portions. The use of separate ques-
tions for winter and summer intakes of milk took seasonal vari-
ations in consumption into account. The participants completed
the questionnaire at home, and answers were checked for com-
pleteness at the research center. Nutrient intake, including cal-
cium and fiber intake, was calculated by using a computerized
version of the Dutch Food Composition Table (33).
For all liquid and solid dairy products, one serving was defined
as 150 and 20 g, respectively. Total dairy consumption was
categorized as low-fat dairy (2% fat) or high-fat dairy (2%
fat). Dairy desserts included yogurt, curds, and custard. The
variable milk included low-fat, skim, and whole milk. The vari-
able yogurt included all low-fat, skim, and whole yogurts.
Statistical analysis
All statistical analyses were performed by using SPSS for
WINDOWS software (version 12.0l; SPSS Inc, Chicago, IL).
Baseline characteristics were reported according to quartiles of
total dairy consumption. We used a linear regression model to
examine linear trends in baseline characteristics across the quar-
tiles of total dairy consumption, modeling the categorical vari-
able of dairy consumption as a continuous independent variable
and the specific characteristic as the dependent outcome vari-
able. A chi-square test was performed to test for trend for cate-
gorical variables.
To examine independent associations between total dairy con-
sumption (and also high-fat or low-fat dairy consumption and
specific dairy product groups) as independent variable and con-
tinuous metabolic variables as dependent variables, multiple lin-
ear regression analyses were performed, and  and their SEs were
reported. To rule out possible bias due to prescribed diets, the
analyses for high-fat dairy and low-fat dairy were also performed
after the exclusion of subjects with known diabetes mellitus or
cardiovascular disease or of subjects who used antihypertensive
or lipid-lowering medication. For determination of potential dif-
ferent effects of individual dairy products, additional regression























analyses were performed separately for the consumption of dairy
desserts, milk, yogurt, and cheese.
Logistic regression analyses were performed to investigate the
association between dairy consumption (independent variable)
and presence of the metabolic syndrome and the individual di-
chotomous variables of the metabolic syndrome (dependent vari-
ables). These associations were expressed as odds ratios (ORs)
and 95% CIs for a serving of dairy foods.
In case of a skewed distribution, variables were logarithmi-
cally transformed before further analyses were performed. All
models were adjusted for age and sex. In multivariate models, we
further adjusted for possible confounders—total energy intake
(EI), alcohol intake, fiber intake, use of antihypertensive medi-
cation, smoking status, physical activity, income, and educa-
tional level. All P values were 2-sided, and P  0.05 was con-
sidered significant.
RESULTS
The median consumption of total dairy products in this pop-
ulation was 4.1 servings/d (interquartile range: 2.9–5.6). The
median daily consumption of milk, yogurt, cheese, and dairy
desserts was 0.7, 0.5, 1.2, and 0.9 servings, respectively. Baseline
characteristics of the population across quartiles of daily servings
TABLE 1








(n  474) P for trend2
Dairy intake (servings/d) 0.00–2.90 2.91–4.13 4.14–5.56 5.57–17.24
Age (y) 62.6  7.13 61.5  7.0 61.7  7.5 61.0  7.4  0.01
Men (%) 43.7 42.6 45.6 47.9 0.38
Total energy intake (kcal) 1796  535 1975  524 2100  510 2388  632  0.01
Fiber intake (g/d) 24.6  7.9 26.1  6.5 27.5  7.4 30.6  8.5  0.01
Saturated fat intake (% of energy) 16.7  3.4 17.0  3.3 17.4  3.1 17.4  3.6  0.01
Polyunsaturated fat intake (% of energy) 8.3  3.5 8.0  3.1 7.7  3.1 7.2  2.9  0.01
Protein intake (% of energy) 13.9  2.7 14.6  2.7 14.8  2.4 15.9  2.9  0.01
Carbohydrate intake (% of energy) 19.1  6.3 20.3  5.8 20.4  5.3 21.8  5.5  0.01
Calcium intake (mg/d) 646  164 927  124 1150  123 1630  330  0.01
Alcohol consumption (%)
No alcohol 31.9 29.5 32.1 30.2 0.43
10 g/d 35.7 39.5 39.5 41.8
10–30 g/d 23.0 22.4 21.1 22.6
30 g/d 9.5 8.6 7.4 5.5
Sports (%) 21.7 29.5 28.1 32.5  0.01
Physical activity (h/d) 4.2  2.6 4.6  2.8 4.2  2.4 4.4  2.8 0.63
Cigarette smoking (%) 38.0 31.2 30.0 25.5  0.01
Income (%)
Low 18.4 18.1 18.1 17.3 0.20
Medium 60.5 54.0 54.6 54.6
High 21.1 27.8 27.2 28.1
Educational level (%)
Low 36.3 34.6 31.0 28.7 0.16
Medium 36.3 37.8 37.8 38.0
High 27.4 27.6 31.2 33.3
BMI (kg/m2) 26.5  3.5 26.7  3.8 26.6  3.4 26.6  3.5 0.98
Waist circumference (cm) 91.0  10.8 91.0  11.4 90.8  10.2 90.8  10.7 0.76
Systolic blood pressure (mm Hg) 138.0  21.2 135.0  20.6 136.2  20.4 133.9  18.7 0.01
Diastolic blood pressure (mm Hg) 82.8  10.2 82.2  10.8 81.9  10.2 81.4  10.1 0.03
LDL cholesterol 4.67  1.16 4.65  1.07 4.62  1.06 4.57  1.08 0.18
HDL cholesterol 1.28 (1.07–1.56)4 1.30 (1.07–1.56) 1.26 (1.07–1.50) 1.28 (1.08–1.54) 0.85
HDL:total cholesterol 0.20  0.07 0.20  0.06 0.20  0.06 0.21  0.06 0.52
Triacylglycerol 1.40 (1.10–2.00) 1.40 (1.10–2.00) 1.40 (1.00–2.00) 1.30 (1.00–1.80) 0.02
Fasting glucose 5.73  1.59 5.80  1.57 5.68  1.26 5.78  1.48 0.90
2-h Glucose (mmol/L) 5.98  2.83 6.28  3.28 6.14  2.99 5.92  2.69 0.63
Antihypertensive medication use (%) 21.5 19.2 20.9 19.0 0.71
Lipid-lowering medication (%) 1.5 1.5 2.3 0.4 0.11
Diabetes (%) 8.6 10.3 9.1 12.1 0.28
CVD (%) 19.6 17.7 20.0 17.3 0.63
Metabolic syndrome (%)5 33.1 30.6 28.9 28.9 0.45
1 CVD, cardiovascular disease.
2 A chi-square test was performed for alcohol consumption, income, and educational level.
3 x  SD (all such values).
4 Median; interquartile range in parentheses (all such values).
5 Presence of the metabolic syndrome was estimated according to the definition of the National Cholesterol Education Program (32).























of total dairy consumption are shown in Table 1. Subjects with
a higher consumption of dairy products were more likely to have
higher total EI, higher fiber intake, higher saturated fat intake,
lower polyunsaturated fat intake, higher protein and carbohy-
drate intake, higher calcium intake, and higher sports activity and
were less likely to smoke (P  0.05). Among the metabolic
variables, there was a significant trend of lower blood pressure
levels and lower triacylglycerol concentration with higher dairy
consumption.
After adjustment for age and sex, total dairy consumption was
borderline significantly inversely associated with systolic and
diastolic blood pressure and with triacylglycerol concentrations
but not with BMI or the other components of the metabolic
syndrome (Table 2, basic models). After adjustment for poten-
tial confounders (adjusted models), the association between
dairy consumption and lower diastolic blood pressure remained,
whereas the association between dairy consumption and higher
fasting glucose became significant. Instead of adjustment for
total EI in the regression models, we performed analyses using
dairy consumption expressed as servings/1000 kcal of EI. These
analyses showed similar results, except that a statistically signif-
icant positive association of dairy consumption with BMI was
also found.
Stratification by the presence of hypertension showed no dif-
ference in the associations between subjects with (n  1236) or
without (n  660) hypertension, except for the associations with
systolic blood pressure (P for interaction  0.023). The associ-
ation of dairy consumption with systolic blood pressure was
stronger in subjects with hypertension (  SE: 0.29  0.23;
P  0.20) than in those without hypertension (  SE: 0.04 
0.17; P  0.80). The association of dairy consumption with
diastolic blood pressure was also stronger in hypertensive sub-
jects (0.34  0.13; P  0.01) than in with subjects without
hypertension (0.19  0.12; P  0.12), but the difference was
not significant (P for interaction  0.445). We tested the dairy
consumption  obesity (BMI  30) interaction for systolic and
for diastolic blood pressure, but the interactions were not signif-
icant (P  0.159 and 0.339, respectively). Nor were the associ-
ations consistently stronger in either of the 2 sexes (P  NS for
all). To investigate a possible threshold effect, we selected only
subjects with calcium concentrations of  700 mg/d (n  286) or
 600 mg/d (n  176). In these groups, median dairy consump-
tion (with interquartile range) was 1.75 (1.17–2.20) servings/d
and 1.35 (0.77–1.83) servings/d, respectively. No statistically
significant associations were found between total dairy con-
sumption and weight or metabolic variables in either low-
calcium group, except for a positive association with waist cir-
cumference (  SE: 1.59  0.75; P  0.04) in the  700 mg
calcium/d group.
When high-fat and low-fat dairy products were distinguished,
consumption of high-fat dairy was significantly inversely asso-
ciated with BMI, waist circumference, triacylglycerol, and insu-
lin and significantly positively associated with HDL-cholesterol
concentrations after adjustment for confounders (Table 2, ad-
justed models). After additional adjustment for BMI, these
associations were no longer significant, except for ln-
triacylglycerides (  SE: 0.01  0.01; P  0.05). In contrast,
low-fat dairy was significantly positively associated with BMI,
TABLE 2
Associations of consumption of total dairy, high-fat dairy, and low-fat dairy (servings/d) with weight and metabolic variables1
Total dairy High-fat dairy Low-fat dairy
  SE P   SE P   SE P
Basic models2
BMI (kg/m2) 0.03  0.043 0.42 0.14  0.05 0.01 0.15  0.05  0.01
Waist circumference (cm) 0.03  0.10 0.80 0.38  0.15 0.01 0.34  0.13 0.01
Systolic blood pressure (mm Hg) 0.34  0.20 0.09 0.72  0.28 0.01 0.03  0.25 0.89
Diastolic blood pressure (mm Hg) 0.22  0.11 0.04 0.32  0.15 0.04 0.08  0.13 0.53
LDL cholesterol (mmol/L) 0.01  0.01 0.27 0.00  0.02 0.94 0.02  0.01 0.21
HDL cholesterol, ln (mmol/L) 0.00  0.00 0.77 0.01  0.00 0.07 0.01  0.00 0.06
Triacylglycerol, ln (mmol/L) 0.01  0.01 0.09 0.02  0.01  0.01 0.00  0.01 0.58
Fasting glucose (mmol/L) 0.02  0.02 0.18 0.02  0.02 0.37 0.05  0.02 0.01
2-h Glucose (mmol/L) 0.01  0.03 0.86 0.01  0.04 0.77 0.02  0.04 0.66
Fasting insulin (mmol/L) 0.14  0.55 0.81 1.23  0.77 0.11 1.21  0.69 0.08
Adjusted models4
BMI (kg/m2) 0.06  0.04 0.17 0.11  0.06 0.06 0.15  0.05  0.01
Waist circumference (cm) 0.07  0.11 0.51 0.39  0.16 0.02 0.36  0.13 0.01
Systolic blood pressure (mm Hg) 0.23  0.22 0.29 0.37  0.31 0.23 0.06  0.25 0.83
Diastolic blood pressure (mm Hg) 0.31  0.12 0.01 0.28  0.17 0.09 0.22  0.14 0.11
LDL cholesterol (mmol/L) 0.02  0.01 0.17 0.02  0.02 0.42 0.01  0.02 0.39
HDL cholesterol, ln (mmol/L) 0.00  0.00 0.94 0.01  0.00 0.05 0.01  0.00 0.10
Triacylglycerol, ln (mmol/L) 0.00  0.01 0.69 0.02  0.01 0.02 0.01  0.01 0.13
Fasting glucose (mmol/L) 0.04  0.02 0.01 0.01  0.02 0.76 0.05  0.02 0.01
2-h Glucose (mmol/L) 0.05  0.04 0.14 0.05  0.05 0.31 0.03  0.04 0.42
Fasting insulin (mmol/L) 0.22  0.61 0.71 1.81  0.85 0.03 0.96  0.70 0.17
1 All values are per serving/d.
2 Adjusted for age and sex.
3 x  SD (all such values).
4 The basic models were further adjusted for total energy intake, fiber intake, level of physical activity, alcohol intake, smoking status, income, educational
level, and antihypertensive medication use.























waist circumference, and fasting glucose concentrations. To ex-
clude possible bias due to prescribed diets, these analyses were
repeated after exclusion of subjects with known diabetes mellitus
or cardiovascular disease and subjects who used antihyperten-
sive or lipid-lowering medication. These exclusions, however,
did not materially change the results (data not shown).
When the relation between 4 main groups of dairy products
and metabolic variables were examined, higher intakes of most
dairy products (ie, dairy desserts, milk, and yogurt) were asso-
ciated with lower systolic and diastolic blood pressures (Table 3,
basic models); these associations were not explained by potential
confounders (Table 3, adjusted models). Higher cheese con-
sumption was associated with a higher BMI.
Total dairy consumption was not significantly associated with
the presence of the metabolic syndrome, after adjustment for
potential confounders. The ORs (95% CI) for the risk of having
the MS in the second, third, and fourth (highest) quartile com-
pared with the lowest (first) quartile of total dairy consumption
were 0.99 (0.74, 1.32), 0.90 (0.67, 1.21), and 1.01 (0.74, 1.39),
respectively. When the 5 individual components of the metabolic
syndrome were dichotomized, only the association between total
dairy consumption and fasting glucose 6.1 mmol/L became
significant when the highest (4th) quartile of total dairy con-
sumption was compared with the lowest (1st) [ORs (95% CI) of
the second, third, and fourth quartiles were 1.16 (0.83, 1.62), 1.10
(0.78, 1.56), and 1.52 (1.06, 2.18), respectively; P for trend 
0.040]. No consistent trends were seen in the relations between
total dairy consumption and the other dichotomous variables
(data not shown).
DISCUSSION
The results of the present study showed a modest inverse
association of the consumption of several dairy products with
blood pressure levels but not with BMI or with other metabolic
variables. Cheese consumption was positively associated with
BMI. High-fat dairy showed inverse associations between BMI
and waist circumference, and low-fat dairy was positively asso-
ciated with BMI and waist circumference. No substantial asso-
ciation was observed between dairy consumption and the pres-
ence of the metabolic syndrome.
Some previous studies (3–12) showed an inverse relation be-
tween total dairy intake and body weight or metabolic risk, but
others (21–23) did not. The heterogeneity of the study popula-
tions and differences in the methods used by the various studies
may be responsible for the observed differences in results. Our
population, on average, was older than those of most other stud-
ies. If an association between dairy consumption and body
weight or metabolic risk exists, we would expect to see these
associations even more clearly in this older population, because
of their longer (lifetime) exposure to risk factors (including diet)
and have a greater prevalence of metabolic disturbances (greater
statistical power). In addition, elderly are more prone to distur-
bances in calcium metabolism because of vitamin D deficiency.
However, we did not find stronger negative associations in our
population. We can only speculate that risk factors other than
dairy consumption may become more important to metabolic
risk in older persons. Furthermore, the mean dairy consumption
in the Netherlands may be higher than that in other countries. A
TABLE 3
Associations of consumption of dairy desserts, milk, yogurt, and cheese (servings/d) with weight and metabolic variables1
Dairy desserts Milk Yogurt Cheese
  SE P   SE P   SE P   SE P
Basic models2
BMI (kg/m2) 0.17  0.113 0.12 0.03  0.06 0.62 0.05  0.14 0.71 0.12  0.08 0.12
Waist circumference (cm) 0.66  0.30 0.03 0.02  0.17 0.93 0.31  0.39 0.42 0.08  0.21 0.69
Systolic BP (mm Hg) 1.76  0.57  0.01 0.74  0.33 0.03 1.52  0.74 0.04 0.20  0.40 0.61
Diastolic BP (mm Hg) 0.66  0.31 0.03 0.55  0.18  0.01 0.28  0.40 0.48 0.09  0.22 0.68
LDL cholesterol (nmol/L) 0.03  0.03 0.30 0.01  0.02 0.56 0.08  0.04 0.05 0.02  0.02 0.36
HDL cholesterol, ln (nmol/L) 0.02  0.01 0.02 0.00  0.00 0.42 0.01  0.01 0.16 0.01  0.01 0.23
Triacylglycerol, ln (nmol/L) 0.03  0.01 0.03 0.00  0.01 0.69 0.03  0.02 0.10 0.02  0.01 0.07
Fasting glucose (nmol/L) 0.09  0.04 0.05 0.05  0.03 0.03 0.01  0.06 0.89 0.00  0.03 0.91
2-h Glucose (nmol/L) 0.11  0.09 0.23 0.05  0.05 0.37 0.01  0.12 0.92 0.01  0.06 0.88
Fasting insulin (nmol/L) 1.99  1.59 0.21 0.84  0.91 0.36 1.88  2.04 0.36 1.52  1.11 0.17
Adjusted models4
BMI (kg/m2) 0.10  0.11 0.34 0.02  0.06 0.73 0.10  0.14 0.48 0.15  0.08 0.04
Waist circumference (cm) 0.44  0.30 0.14 0.03  0.17 0.88 0.05  0.38 0.90 0.14  0.21 0.50
Systolic BP (mm Hg) 1.26  0.58 0.03 0.57  0.34 0.09 1.28  0.74 0.08 0.37  0.42 0.37
Diastolic BP (mm Hg) 0.58  0.31 0.06 0.57  0.18  0.01 0.35  0.40 0.37 0.00  0.22 0.99
LDL cholesterol (nmol/L) 0.03  0.03 0.32 0.00  0.02 0.92 0.06  0.04 0.18 0.02  0.02 0.53
HDL cholesterol, ln (nmol/L) 0.02  0.01 0.04 0.01  0.00 0.09 0.02  0.01 0.07 0.00  0.01 0.91
Triacylglycerol, ln (nmol/L) 0.01  0.01 0.38 0.01  0.01 0.51 0.00  0.02 0.82 0.01  0.01 0.54
Fasting glucose (nmol/L) 0.06  0.05 0.22 0.07  0.03 0.01 0.02  0.06 0.69 0.03  0.03 0.41
2-h Glucose (nmol/L) 0.02  0.09 0.87 0.07  0.05 0.17 0.07  0.12 0.58 0.03  0.06 0.60
Fasting insulin (mmol/L) 1.79  1.63 0.27 0.35  0.93 0.71 1.59  2.05 0.44 2.15  1.15 0.06
1 BP, blood pressure. All values are per serving/d.
2 Adjusted for age and sex.
3 x  SD (all such values).
4 The basic models were further adjusted for total energy intake, fiber intake, level of physical activity, alcohol intake, smoking status, income, educational
level, and antihypertensive medication use.























possible threshold effect has been suggested at a calcium intake
of 600–700 mg/d (14, 25). However, when only the participants
in our study who had a low calcium intake (700 or 600 mg/d)
were selected, no significant negative associations of dairy con-
sumption with BMI or metabolic outcomes were found.
Inverse associations of dairy consumption with blood pressure
were observed in earlier studies, as well as in the current study,
but the associations with other components of the metabolic
syndrome in those studies (10, 12, 24, 26) were weaker. Asso-
ciations of dairy consumption with metabolic variables other
than blood pressure were not found in the population in the
current study. A significant, positive association between dairy
consumption and fasting glucose concentrations was observed,
but the effect was very small and probably not of biological
importance. The difference with previous studies may be due to
the higher mean intake of dairy in our population. However,
selection of subjects with low calcium intake did not reveal
considerably different results. It was previously suggested that
the effect of calcium on blood pressure is greater in persons who
already have hypertension (15), and this may be the case also for
dairy consumption. Indeed, in additional analyses, after stratify-
ing for hypertension, we observed slightly stronger associations
between dairy consumption and blood pressure in the hyperten-
sive subjects than in those without hypertension. This finding
suggests that dairy products may be particularly beneficial in
subjects with high risk of hypertension or in subjects who already
have elevated blood pressure, which is consistent with the find-
ing that particularly salt-sensitive individuals respond to dietary
calcium interventions (15). The subjects in the current study who
had elevated blood pressure may represent a selection of salt-
sensitive persons, in whom there is a tight relation between so-
dium and calcium excretion (ie, an increase in either cation in-
creases the excretion of the other). In such subjects, increasing
salt consumption increases urinary calcium loss, which may be
prevented by increasing dietary calcium. Salt-insensitive per-
sons depend more on intracellular calcium stores and are less
likely to respond to dietary calcium (15).
In previous studies, the association between dairy consump-
tion and the risk of type 2 diabetes was stronger for low-fat dairy
than for high-fat dairy, possibly as a result of the unfavorable
effect of the higher amounts of saturated fat in high-fat dairy (8,
9). This distinction between high- and low-fat dairy was not
apparent, however, for the risk of the metabolic syndrome in
young, obese adults (10) or in the population of the current study.
Our results suggested favorable associations between high-fat
dairy (rather than low-fat dairy) and BMI and between high-fat
dairy and waist circumference, after adjustment for putative con-
founders. A beneficial association of particularly dairy desserts,
as was found in the current study, was previously observed (10).
The favorable associations for the consumption of dairy des-
serts and high-fat dairy observed in the current study population
could possibly be explained by an increased secretion of the
incretin hormone glucagon-like peptide 1 (GLP-1) in the gastro-
intestinal tract and by that hormone’s signaling in the central
nervous system (34) in response to saturated fatty acids in dairy
products (35, 36). A high concentration of GLP-1 causes an
inhibition of gastric emptying (37, 38) and an increase in glucose-
induced insulin secretion (39). The time of the day at which dairy
products are consumed may be of importance to the effects of
GLP-1. Thus, when a dairy product is consumed after a meal,
GLP-1 may cause prolonged satiety by direct central nervous
system effect and by inhibiting gastric emptying, which may
result in a decreased intake of snacks after the meal. The unex-
pected associations of low-fat dairy with higher BMI and of
high-fat dairy with lower BMI may also result from the phenom-
enon that obese people are more likely to consume low-fat dairy
because they are obese (reversed causation). Because of the
cross-sectional design of the study, the causality of the associa-
tions could not be investigated.
Recent studies observed an inverse association between dairy
consumption and the prevalence of the metabolic syndrome (10,
12, 40). This finding was not confirmed by our study. According
to the study by Pereira et al (10), the inverse association between
dairy consumption and the metabolic syndrome existed only in
overweight adults. In the current study population, the associa-
tions between dairy consumption and metabolic variables did not
different significantly between obese and nonobese subjects.
Some limitations of the current study should be considered.
First, the use of self-reports of usual dietary intake has undoubt-
edly led to some misclassification of dairy consumption. Never-
theless, the food-frequency questionnaire used in the current
study was compared with a modified dietary history, and the
results suggested reasonable accuracy (33). Second, because all
analyses were cross-sectional, causality cannot be proven, and,
although we adjusted for lifestyle factors, dairy consumption
may simply reflect a healthy diet or lifestyle. Further research
into the role of food patterns in the development of obesity and
metabolic disturbances, particularly prospective studies, is
needed.
In conclusion, a larger consumption of dairy products was
associated with modestly lower blood pressure levels but not
with body weight or other metabolic traits. These results are in
line with the suggested favorable effects of the consumption of
dairy products on blood pressure, but they do not support the
hypothesis that higher dairy consumption is beneficial for
weight.
CDAS, GN, RJH, LMB, and JMD were responsible for the design of the
study and for data collection; MBS and AAWAvdH were responsible for
analysis of the data; RMvD, CDAS, GJH, GN, RJH, LMB, and JMB con-
tributed to the presentation or interpretation (or both) of the results; MBS and
AAWAvdH wrote the draft of the paper; and MBS was responsible for the
final version of the manuscript. None of the authors had a personal or finan-
cial conflict of interest.
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